আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
doloproct endaþarmsstíll 1 mg + 40 mg
karo pharma ab* - fluocortolonum pívalat; lidocainum hýdróklóríð - endaþarmsstíll - 1 mg + 40 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken stungulyf, lausn 1 mg/ml
recordati ireland limited* - metoprololum tartrat - stungulyf, lausn - 1 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
pentocur (tiopental abcur) stungulyfsstofn, lausn 1 g
abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
kaletra
abbvie deutschland gmbh co. kg - lopinavir, rítónavír - hiv sýkingar - antivirals for systemic use, protease inhibitors - kaletra er ætlað ásamt öðrum antiretroviral lyf til meðferð hiv veira (hiv-1) sýkt fullorðnir, unglingum og börn á aldrinum 14 daga og eldri. val á kaletra að meðhöndla próteasahemla upplifað hiv-1 sýkt sjúklingar ætti að vera byggt á einstökum veiru mótstöðu próf og meðferð sögu af sjúklingum.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftriaxon fresenius kabi stungulyfs-/innrennslisstofn, lausn 1 g
fresenius kabi ab - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn, lausn - 1 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
cefazolina normon stungulyfsstofn og leysir, lausn í bláæð 1 g
laboratorios normon, s.a. - cefazolinum natríum - stungulyfsstofn og leysir, lausn - í bláæð 1 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
propolipid stungulyf/innrennslislyf, fleyti 10 mg/ml
fresenius kabi ab - propofolum inn - stungulyf/innrennslislyf, fleyti - 10 mg/ml
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftriaxon fresenius kabi innrennslisstofn, lausn 2 g
fresenius kabi ab - ceftriaxonum dínatríum - innrennslisstofn, lausn - 2 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) innrennslislyf, lausn 2 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml